Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas by Maëlle Dumont, Régis Peffault de Latour, Caroline Ram-Wolff, Martine Bagot, Adèle de Masson

“…Cutaneous T-cell lymphomas (CTCLs) are non-Hodgkin lymphomas that develop primarily in the skin. They account for almost 80% of primary cutaneous lymphomas. …”
Get full text

Hijacking of the AP-1 Signaling Pathway during Development of ATL by Hélène Gazon, Benoit Barbeau, Jean-Michel Mesnard, Jean-Marie Peloponese

“…Deregulated expression of AP-1 transcription factors is implicated in various lymphomas such as classical Hodgkin lymphomas, anaplastic large cell lymphomas, diffuse large B-cell lymphomas, and adult T-cell leukemia. …”
Get full text

A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy by Cesare Mazzaro, Luca Quartuccio, Luigi Elio Adinolfi, Dario Roccatello, Gabriele Pozzato, Riccardo Nevola, Maurizio Tonizzo, Stefano Gitto, Pietro Andreone, Valter Gattei

“…Experimental and clinical data support a causal association for many extrahepatic manifestations and HCV infection, which include mixed cryoglobulinemia, non-Hodgkin lymphomas (NHL), cardiovascular disease, insulin resistance, type 2 diabetes, neurological and psychiatric disease and other rheumatic diseases. …”
Get full text

SHC014748M, a novel selective inhi-bitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B cell lymphomas and chronic lymphocytic leukemia by Lei Fan, Chao Wang, Liwen Zhao, Zhiqiang Wang, Xian Zhang, Xiaorong Liu, Lei Cao, Wei Xu, Jianyong Li

“…This provides a rationale for the development of small molecule inhibitors that selectively target p110δ for patients with indolent non-Hodgkin lymphomas. Here in this paper, we comprehensively evaluated the in vitro and in vivo antitumor activity of SHC014748M, an oral selective inhibitor of PI3Kδ under Phase I clinical evaluation. …”
Get full text

Prognostic impact of MYD88 mutation, proliferative index and cell origin in diffuse large B cell lymphoma by Laura Fogliatto, Kamila Castro Grokoski, Yuri Machado Strey, Tito Vanelli, Christina Garcia da Silva Fraga, Marines Bizarro Barra, Fernanda Correa Pinto, Israel Bendit, Claúdia Giuliano Bica

“…Background: Diffuse large B-cell lymphoma, among non-Hodgkin lymphomas, is one of the most frequent subtypes. …”
Get full text

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus by Mohsen eNavari, Mohsen eNavari, Mohsen eNavari, Fabio eFuligni, Maria Antonella Laginestra, Maryam eEtebari, Maria Raffaella eAmbrosio, Maria Rosaria Sapienza, Maura eRossi, Giulia eDe Falco, Giulia eDe Falco, Davide eGibellini, Claudio eTripodo, Stefano A. Pileri1, Lorenzo eLeoncini, Pier Paolo ePiccaluga

“…Although the precise role of the virus in the pathogenesis of different lymphomas is largely unknown, it is well recognized that the expression of viral latent proteins and miRNA can contribute to its patoghenetic role.In this study, we compared the gene and miRNA expression profile of two EBV-associated aggressive B non-Hodgkin lymphomas known to be characterized by differential expression of the viral latent proteins aiming to dissect the possible different contribution of such proteins and EBV-encoded miRNAs.By applying extensive bioinformatic inferring and an experimental model, we found that EBV+ Burkitt lymphoma presented with significant over-expression of EBV-encoded miRNAs that were likely to contribute to its global molecular profile. …”
Get full text

METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE RE... by Ye. A. Dudnikova, V. I. Chernov, A. V. Muravleva, T. L. Kravchuk, R. V. Zelchan, A. A. Medvedeva, O. D. Bragina, Ye. L. Simolina, N. O. Popova, V. V. Vysockaja, N. M. Lukina, V. A. Shatalova, O. V. Shpileva, A. V. Goldberg, V. Ye. Goldberg

“…Primary breast lymphoma accounts for 1.7–2.2 % of all extranodal nonHodgkin lymphomas. Diffuse large B-cell lymphoma is the most common histological type occurring usually as a unilateral palpable tumor in middle-aged women. …”
Get full text

Comparison between diffusion-weighted magnetic resonance and positron-emission tomography in the evaluation of treated lymphomas with mediastinal involvement by Francesca Di Giuliano, Eliseo Picchi, Noemi Pucci, Silvia Minosse, Valentina Ferrazzoli, Giulia Pizzicannella, Cecilia Angeloni, Daniela Nasso, Agostino Chiaravalloti, Francesco Garaci, Roberto Floris

“…Results We included 21 patients with mediastinal Hodgkin and non-Hodgkin lymphomas who showed residual masses on PET-CT imaging at end of treatment and underwent DWIBS-Magnetic Resonance Imaging (MRI). …”
Get full text

Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives by Dominic Kaddu-Mulindwa, Lorenz Thurner, Konstantinos Christofyllakis, Moritz Bewarder, Igor Age Kos

“…Extranodal marginal zone lymphoma (EMZL) encompasses a subgroup of non-Hodgkin lymphomas that often present with localized involvement and may manifest in a diversity of organs and tissues. …”
Get full text

Nijmegen breakage syndrome: case report and review of literature by Brahim El Hasbaoui, Abdelhkim Elyajouri, Rachid Abilkassem, Aomar Agadr

“…Prognosis is generally poor due to the extremely high rate of malignancies.We present here a case of Nijmegen breakage syndrome associated with Hodgkin lymphomas and combined variable immunodeficiency.…”
Get full text

Outcomes of COVID‐19 in patients with lymphomas participating in registered clinical trials: A real‐world study from China in the Omicron outbreak era by Peng Sun, Hang Yang, Baitian Zhao, Yu Wang, Man Nie, Kangming Huang, Zhiming Li

“…Patients with indolent B‐cell non‐Hodgkin lymphomas were less likely to be hospitalized for COVID‐19. …”
Get full text

CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China by Yanfen Feng, Huilan Rao, Yiyan Lei, Yuhua Huang, Fang Wang, Yu Zhang, Shaoyan Xi, Qiuliang Wu, Jianyong Shao

“…Abstract Background Mature T-cell and natural killer (NK)-cell lymphomas compose a heterogeneous group of non-Hodgkin lymphomas, and extranodal NK/T-cell lymphoma, nasal type (ENKTL) is an aggressive subtype with sporadic CD30 expression. …”
Get full text

Master of mimicry: Rare primary cutaneous anaplastic large cell lymphoma presenting as fungating parotid tumor–case report and review by Heng, Sophia Si Ling, Fatimah Mat Johar, Thevarasan Ganandran, Nurul Anis Mohd Fauzi, Faezahtul Arbaeyah Hussain, Wan Azman Wan Sulaimana

“…They fall within non-Hodgkin's lymphomas spectrum. Commonly misdiagnosed, this malignancy involving the skin has favorable prognosis. …”
Get full text
Get full text

Can We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation. by Emmanuel Jouglar, Antoine Wagner, Grégory Delpon, Loïc Campion, Philippe Meingan, Valérie Bernier, Charlotte Demoor-Goldschmidt, Marc-André Mahé, Thomas Lacornerie, Stéphane Supiot

“…Dosimetric values were compared using the Wilcoxon signed-rank test.The dose distribution of 20 clinical cases with a median age of 8 years (range 1-14) were calculated with different doses to the PTV: 5 medulloblastomas (36 Gy), 3 left-sided and 2 right-sided nephroblastomas (14.4 Gy to the tumor + 10.8 Gy boost to para-aortic lymphnodes), 1 left-sided and 4 right-sided or midline neuroblastomas (21 Gy) and 5 Hodgkin lymphomas (19.8 Gy to the para-aortic lymphnodes and spleen). …”
Get full text

Effect of itraconazole and fluconazole on the pharmacokinetics of valemetostat: An open‐label, phase I study in healthy subjects by Masaya Tachibana, Shunji Matsuki, Yutaro Maekawa, Kana Kuroda, Takako Shimizu, Junko Tsutsumi, Hitoshi Ishizuka

“…Abstract Valemetostat tosylate (valemetostat) is an oral, potent, dual inhibitor of enhancer of zeste homolog (EZH) 2 and EZH1 under investigation for the treatment of cancer, including non‐Hodgkin's lymphomas and solid tumors. Itraconazole and fluconazole are antifungal medications often used as typical inhibitors of cytochrome P450 3A (CYP3A [itraconazole and fluconazole]) and P‐glycoprotein (P‐gp [itraconazole]) in drug–drug interaction studies. …”
Get full text

Follicular T-cell lymphoma: A rare entity by O.T. Eryilmaz, N. Dogruyol, A. Ozagari, F. Kabukcuoglu

“…Conclusion: Peripheral T-cell lymphomas (PTCLs) constitute about 12% of all non-Hodgkin lymphomas, of which the unspecified category is the most common subtype. …”
Get full text

A Push to Consider Mantle Cell Lymphoma in Adults with Leukemia/Lymphoma with Blastoid Morphology by Nkechi Arinze, Nivin Omar, Amany Keruakous, Ravindra Kolhe, Natasha Savage

“…Mantle cell lymphoma (MCL) is an intermediate-grade B-cell lymphoma, representing 2.8% of all non-Hodgkin lymphomas in the US. It is associated with t(11;14)(q13; q23), which leads to the overexpression of cyclin D1, consequently promoting cell proliferation. …”
Get full text

In-vivo fusion of human cancer and hamster stromal cells permanently transduces and transcribes human DNA. by David M Goldenberg, Robert J Rooney, Meiyu Loo, Donglin Liu, Chien-Hsing Chang

“…Here, we analyzed gene expression profiles of 3 different hybrid tumors first generated in the hamster cheek pouch after human tumor grafting, and then propagated in hamsters and in cell cultures for years: two Hodgkin lymphomas (GW-532, GW-584) and a glioblastoma multiforme (GB-749). …”
Get full text

Five-year mortality rate in an ophthalmic ward in Zimbabwe by Pamidzai Madzima, Rangarirai Masanganise

“…Theorbital malignancies included ocular surface squamous neoplasia (OSSN), retinoblastomaand non-Hodgkins lymphoma (NHL). The most common probable cause of death was OSSN which accounted for 9 (60%) of the deaths. …”
Get full text

Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India by K N Lokesh, M C. Suresh Babu, K C Lakshmaiah, K Govind Babu, Smitha C Saldanha, D Loknatha, Linu Abraham Jacob, S Vishwanath, C S Premalatha, P R Kiran

“…Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most frequent non-Hodgkins lymphoma in the elderly. With the rising proportion of older persons in India, it is important to study current patterns and management of this disease, given that data in this regard are scarce in Indian settings. …”
Get full text